Current potential medications for NAFLD include insulin sensitizers such as metformin and thiazolidinediones (pioglitazone and rosiglitazone), lipid-lowering drugs (atorvastatin, fenofibrate, and ezetimibe), antioxidants (vitamin E and pentoxifylline), glucagon-like peptide 1 analogues (exenatide), ursodeoxycholine acid, obeticholic acid, and ω-3 fatty acids [45]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.